INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

159 studies · page 4 of 7

2013 / Narrative review

Reducing salt consumption decreases blood pressure and the incidence of cardiovascular disease with no reported deleterious effects.

This review evaluates the evidence regarding salt consumption and health outcomes. High salt intake is identified as a major cause of increased blood pressure and is linked to stroke, left ventricular hypertrophy, renal disease, obesity, renal stones, and stomach cancer. Lowering salt intake reduces blood pressure and cardiovascular disease incidence, demonstrating high cost-effectiveness without deleterious effects. In France, targets are set at <8 g/day for men and <6.5 g/day for women and children, with population reduction requiring food industry participation and consumer education.

Delahaye F Arch Cardiovasc Dis, 2013. PMID 23769406

2013 / Narrative review

Evidence suggests potatoes may favorably impact cardiometabolic measures, but epidemiological results vary and clinical trials remain needed.

This review examined the role of potatoes and their components in cardiometabolic health. Studies in animals and humans show favorable impacts on measures such as lowering blood pressure, improving lipid profiles, and decreasing inflammatory markers. However, human cohort findings are mixed depending on whether potatoes are consumed as part of a healthy lifestyle or with calorie-dense foods, and epidemiological data are limited by inconsistent dietary pattern definitions and confounding controls. Clinical trial data regarding postprandial glycemic response and weight management remain sparse.

Shows an association, not proof of cause and effect.

McGill CR, Kurilich AC, Davignon J Ann Med, 2013. PMID 23855880

2013 / Narrative review

Habitual intake of about 2 to 3 cups of coffee daily was linked to neutral to beneficial effects across many cardiovascular and mortality outcomes.

This review examined evidence regarding the health effects of chronic coffee consumption. Epidemiological data indicate that coffee intake is linked to reduced risks of type 2 diabetes, hypertension, and both cardiovascular and all-cause mortality, as well as neutral to beneficial effects on coronary heart disease, congestive heart failure, arrhythmias, and stroke. Consuming approximately 2 to 3 cups per day appears safe for most studied outcomes. The authors caution that most available data are observational, and potential benefits must be weighed against risks like anxiety, insomnia, palpitations, bone loss, and fracture risk.

Shows an association, not proof of cause and effect.

O'Keefe JH, Bhatti SK, Patil HR, et al. J Am Coll Cardiol, 2013. PMID 23871889

2013 / Perspective / commentary

A perspective article examines whether lower mortality observed in overweight individuals may be an artifact of methodological limitations.

Evidence indicates that overweight and obesity increase the risk of chronic diseases such as hypertension, type 2 diabetes, cardiovascular diseases, and cancer. A recent meta-analysis reported that overweight individuals (BMI 25.0–29.9) had a significantly lower mortality risk compared with normal-weight individuals (BMI <25.0), and Class 1 obesity (BMI 30–34.9) was linked to marginally reduced mortality. This perspective discusses why these findings are likely an artifact of methodological limitations and considers the clinical and public health implications.

Shows an association, not proof of cause and effect.

Tobias DK, Hu FB Obesity (Silver Spring), 2013. PMID 24078231

2013 / Scientific statement / review

Salt reduction lowers blood pressure and is suggested to improve cardiovascular disease risk, with potentially stronger effects on stroke than heart disease.

A scientific statement from the Japanese Society of Hypertension reports that dietary salt intake is closely associated with blood pressure levels, with stricter reduction more markedly decreasing blood pressure. Observational and intervention studies suggested that salt restriction improved the risk of cardiovascular diseases, potentially reducing stroke risk more than ischemic heart disease. Small-scale studies demonstrated that excess salt increased risks of left ventricular hypertrophy, heart failure, urinary protein/albumin levels, and end-stage renal failure. The authors note that mean salt intake in Japan is markedly high and conclude salt reduction is essential for prevention and treatment.

Ando K, Kawarazaki H, Miura K, et al. Hypertens Res, 2013. PMID 24152613

2013 / Narrative review

Intensive control of multiple risk factors, including diet and weight, can reduce stroke risk by 80% or more.

Stroke prevention is critical due to an aging population and escalating direct healthcare costs. Comprehensive risk factor management can reduce stroke risk by 80% or more. Key requirements, roughly in order of importance, include smoking cessation, healthy weight maintenance, a Cretan Mediterranean diet, blood pressure control, lipid-lowering drugs, antiplatelet and anticoagulant therapies, and carotid interventions.

Spence JD F1000Prime Rep, 2013. PMID 24167723

2013 / Narrative review

Direct evidence linking sodium intake to vascular risk is inconsistent, despite clear links between sodium and blood pressure.

This review evaluates the evidence connecting sodium intake, blood pressure, and vascular risk. The authors state there is unequivocal evidence that increased sodium intake is associated with higher blood pressure and that increased blood pressure leads to higher vascular disease risk, but direct evidence linking sodium intake to vascular risk is inconsistent and confusing. The review considers how vested interests have exploited this inconsistency and argues that legislation is the only tool likely to reduce this dietary additive.

Neal B, Land MA, Woodward M Curr Hypertens Rep, 2013. PMID 24170199

2013 / Narrative review

Maternal consumption of polyphenol-rich foods in late pregnancy may influence fetal ductus arteriosus flow dynamics via anti-inflammatory pathways.

This review explores the effects of maternal dietary polyphenols on the fetal ductus arteriosus during late pregnancy. The ductus arteriosus directs 80-85% of right ventricular output to the descending aorta, and constriction can cause complications such as heart failure, hydrops, neonatal pulmonary hypertension, and death. Evidence suggests that herbs, fruits, nuts, and polyphenol-rich foods possess anti-inflammatory actions that inhibit prostaglandin synthesis, potentially altering ductal flow dynamics during the third trimester.

Zielinsky P, Busato S Birth Defects Res C Embryo Today, 2013. PMID 24339037

2013 / Narrative review

Type 2 diabetes mellitus is increasingly reported in youth globally, with lifestyle intervention identified as the initial treatment of choice.

This review discusses the emerging clinical problem of type 2 diabetes mellitus in children and adolescents, noting an increasing global prevalence across ethnicities even where obesity rates have plateaued. High-risk groups include specific ethnic minorities, youth with obesity, family history of type 2 diabetes, or signs of insulin resistance. Screening is considered meaningful due to frequent mild or asymptomatic presentations. Lifestyle intervention is highlighted as the primary treatment of choice, followed by pharmacological options such as metformin.

Reinehr T World J Diabetes, 2013. PMID 24379917

2013 / Expert panel consensus guideline update

An expert panel updated consensus guidelines on fasting therapy, noting beneficial effects in various chronic diseases, especially rheumatic conditions.

An expert panel updated the 2002 consensus guidelines on medical fasting therapy. Fasting demonstrates beneficial effects in various chronic diseases, with the highest level of evidence observed for rheumatic diseases. Preliminary data also indicate benefits for metabolic diseases, hypertension, pain syndromes, chronic inflammatory diseases, atopic diseases, psychosomatic disorders, and disease prevention in healthy individuals. The panel states that fasting interventions should be guided by trained and certified physicians or therapists to ensure safety and quality standards.

Wilhelmi de Toledo F, Buchinger A, Burggrabe H, et al. Forsch Komplementmed, 2013. PMID 24434758

2013 / Narrative review

Fasting therapy and intermittent fasting show potential benefits for chronic inflammatory and degenerative diseases in clinical and experimental evidence.

This review evaluates the evidence surrounding deliberate and medically supervised modified fasting (200-500 kcal/day for 7-21 days) for disease prevention and treatment. Observational and empirical evidence suggests efficacy in rheumatic diseases, chronic pain syndromes, hypertension, and metabolic syndrome, with randomized controlled trials confirming benefits of fasting followed by a vegetarian diet in rheumatoid arthritis. Additionally, intermittent fasting is associated with deceleration or prevention of chronic degenerative diseases and may serve as an adjunct to cancer chemotherapy.

Michalsen A, Li C Forsch Komplementmed, 2013. PMID 24434759

2012 / Program evaluation / narrative review

The UK Food Standards Agency's salt reduction programme coincided with a drop in population salt intake from 9.5 g/d to 8.6 g/d.

This paper describes the UK Food Standards Agency's salt reduction programme between 2003 and 2010. Urinary sodium data showed a statistically significant reduction in average adult salt intake from 9.5 g/d in 2000-2001 to 8.6 g/d in 2008. Food monitoring showed reductions up to 70% in some items, and consumer awareness increased, with 43% of adults in 2009 claiming to make an effort to reduce dietary salt compared to 34% in 2004. Significant challenges remain in achieving the recommended population average of 6 g/d.

Wyness LA, Butriss JL, Stanner SA Public Health Nutr, 2012. PMID 21729460

2012 / Narrative review

Evidence for cinnamon's anti-diabetic effects is strong in animal models but conflicting in human clinical trials.

This review summarizes scientific literature on Cinnamomum aromaticum (Cassia) and Cinnamomum zeylanicum bark products. While in vitro and animal studies consistently demonstrated pronounced anti-diabetic and hypoglycemic activities alongside potential antimicrobial, antioxidant, and lipid-lowering properties, results from available human clinical trials remain conflicting. The authors emphasize the need for well-defined, adequately powered randomized controlled clinical trials before recommending cinnamon as an effective human treatment.

Bandara T, Uluwaduge I, Jansz ER Int J Food Sci Nutr, 2012. PMID 22007625

2012 / Narrative review

In clinical trials, cinnamon consumption has produced varying findings, with fasting glucose levels being the only consistently improved measurement.

This review evaluates the evidence and mechanisms of cinnamon for managing insulin resistance, metabolic syndrome, and type 2 diabetes. Human clinical trials have yielded mixed results; while some showed no benefits, others noted improvements in cholesterol, systolic blood pressure, insulin sensitivity, and postprandial glucose. However, the only outcome consistently improved by cinnamon consumption across trials was fasting glucose levels. The authors note it is premature to suggest cinnamon supplementation based on the current evidence, and systematic large-scale clinical trials are needed.

Rafehi H, Ververis K, Karagiannis TC Diabetes Obes Metab, 2012. PMID 22093965

2012 / Narrative review

Almost 4 out of 5 non-communicable disease deaths occur in low- and middle-income countries.

Non-communicable diseases (NCDs) like cardiovascular disease, cancer, and diabetes have shown a dramatic increase in the developing world, particularly in highly populated transition countries. Almost 4 out of 5 NCD-based deaths now occur in low- and middle-income countries. This trend is driven by factors including globalization, supermarket growth, rapid urbanization, and sedentary lifestyles leading to overweight or obesity. A high-quality diet including functional food or ingredients, physical activity, and non-smoking policies are noted as promising preventive strategies.

Wagner KH, Brath H Prev Med, 2012. PMID 22178469

2012 / Narrative review

A global nutrition transition toward processed foods and reduced activity has coincided with widespread increases in obesity and related chronic diseases.

This review describes the global nutrition transition that began in the 1970s, characterized by shifts toward processed foods, away-from-home intake, edible oils, and sugar-sweetened beverages alongside decreased physical activity. Rapid increases in obesity and overweight are now documented globally, including in urban and rural areas of the poorest countries in sub-Saharan Africa and South Asia. Despite these widespread dietary and activity challenges, few countries are currently engaged in serious preventive efforts.

Shows an association, not proof of cause and effect.

Popkin BM, Adair LS, Ng SW Nutr Rev, 2012. PMID 22221213

2012 / Narrative review

Review summarizes evidence linking inadequate sleep with increased vulnerability to obesity and cardiometabolic disease.

This review evaluated evidence on inadequate sleep as a risk factor for obesity and cardiometabolic disease. Experimental studies reported that short-term sleep restriction is associated with impaired glucose metabolism, dysregulation of appetite, and increased blood pressure. Observational studies reported associations between short sleep duration (<6 h per night) and increased body mass index, obesity, prevalent diabetes, and hypertension, with some studies also linking long sleep (>8 h per night) to cardiometabolic disease. A few prospective studies found an increased risk of weight gain, incident diabetes, and incident hypertension associated with inadequate sleep.

Shows an association, not proof of cause and effect.

Knutson KL Am J Hum Biol, 2012. PMID 22275135

2012 / Review

Review notes studies indicating blood pressure reductions following quercetin supplementation in hypertensive animals and humans.

This review evaluates evidence on quercetin's potential therapeutic role and blood pressure-lowering mechanisms. The authors note that work in hypertensive animals and humans (>140 mm Hg systolic and >90 mm Hg diastolic) indicates a decrease in blood pressure after quercetin supplementation. Proposed mechanisms include antioxidant effects, inhibition of angiotensin-converting enzyme activity, and improved endothelial function, though most mechanisms have been identified in animal models and relatively few have been corroborated in humans.

Larson AJ, Symons JD, Jalili T Adv Nutr, 2012. PMID 22332099

2012 / Narrative review

Dietary fiber supplementation may play an important role in long-term obesity management through effects on glucoregulation, appetite, and satiety.

This review discusses the health implications of inadequate dietary fiber intake. Evidence points to an association between a lack of fiber intake and conditions such as ischemic heart disease, stroke, type 2 diabetes, obesity, hypertension, and gastrointestinal disorders. Beyond physical properties that influence food energy density, fiber directly impacts microbiological, biochemical, and neurohormonal effects through modified digestion kinetics and metabolism into short-chain fatty acids. Consequently, functional fiber supplementation may play an important role in long-term obesity management via glucoregulation, appetite, and satiety.

Shows an association, not proof of cause and effect.

Lyon MR, Kacinik V Curr Obes Rep, 2012. PMID 22611521

2012 / Narrative review / roundtable summary

Over 90% of American adults and children do not meet daily fiber recommendations, leaving intakes at about half the recommended amount.

A roundtable session gathered nutrition researchers, educators, and communicators to evaluate solutions for the American dietary fiber gap. Despite promotion over the past decade, fiber intake has remained flat at roughly half of daily recommendations, leaving over 90% of adults and children short of targets. The discussions emphasized consumer and professional education to enhance acceptance and inclusion of grain-based foods with added fiber as a realistic approach to boost intake within daily energy goals.

Clemens R, Kranz S, Mobley AR, et al. J Nutr, 2012. PMID 22649260

2012 / Authors' perspective review

Authors conclude 200 mg per day is the optimum dietary intake of vitamin C for most adults based on combined scientific evidence.

This perspective review evaluated evidence regarding the optimal intake of vitamin C in humans, arguing that standard Phase III drug trials are ill-suited for essential nutrients. The authors noted that evidence from prospective cohort studies and Phase II RCTs indicates vitamin C supplementation reduces hypertension, endothelial dysfunction, chronic inflammation, and Helicobacter pylori infection. Based on combined data from human metabolic, pharmacokinetic, observational, and Phase II studies, the authors conclude that 200 mg/day is the optimum intake for most adults to maximize health benefits with minimal risk.

Frei B, Birlouez-Aragon I, Lykkesfeldt J Crit Rev Food Sci Nutr, 2012. PMID 22698272

2012 / Narrative review

Twin gestations carry higher maternal risks compared with singletons, including preeclampsia, nutritional deficiencies, and postpartum hemorrhage.

This review examines maternal risks associated with carrying multiple gestations. Compared with singleton pregnancies, twin pregnancies present increased maternal risks across antepartum, intrapartum, and postpartum periods, including preeclampsia, other hypertensive disorders, antepartum hospitalization for preterm labor or abnormal bleeding, nutritional deficiencies, cesarean delivery, and postpartum hemorrhage. The review notes that women carrying twins may benefit from early education, close monitoring, physical therapy, and nutrition counseling.

Young BC, Wylie BJ Semin Perinatol, 2012. PMID 22713496

2012 / Narrative review

Viscous soluble fibers provide specific benefits including lowering cholesterol, improving glycemic control, and normalizing stool form, unlike nonviscous fibers.

This review examined the health benefits of viscous versus nonviscous soluble fibers based on scientific literature and evidence-based guidelines. The authors concluded that many health benefits of fiber directly correlate with the viscosity of soluble fibers when hydrated. Clinically, increasing chyme viscosity with viscous soluble fiber lowers cholesterol, improves glycemic control in type 2 diabetes, normalizes stool form in constipation and diarrhea, and improves clinical measures of metabolic syndrome such as lipoproteins, glycemic control, BMI/weight, and blood pressure.

Chutkan R, Fahey G, Wright WL, et al. J Am Acad Nurse Pract, 2012. PMID 22845031

2012 / Narrative review

Moderate reduction of salt intake is associated with reduced blood pressure and lower cardiovascular and cerebrovascular events in hypertensive individuals.

This review discusses dietary salt intake reduction in hypertensive patients. Recent meta-analyses of randomized controlled trials cited in the text indicate that moderate salt reduction is associated with reduced blood pressure and, in perspective, reduced cardiovascular and cerebrovascular events in hypertensive individuals. Patient response to salt reduction varies, primarily due to inconsistent compliance and, to a lesser extent, individual differences in blood pressure salt sensitivity.

Strazzullo P, D'Elia L, Cairella G, et al. High Blood Press Cardiovasc Prev, 2012. PMID 22867091